| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2477* | 2021 |
| Tuberculosis: commentary on a reemergent killer BR Bloom, CJL Murray Science 257 (5073), 1055-1064, 1992 | 2095 | 1992 |
| WHO COVID-19 case definition (2021 World Health Organization WHO COVID-19 case definition, 2020 | 1968* | 2020 |
| RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19 P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ... N Engl J Med 384 (8), 693-704, 2021 | 638* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 628* | 2022 |
| Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ... The lancet HIV 5 (8), e438-e447, 2018 | 595 | 2018 |
| Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis FM Islam, J Wu, J Jansson, DP Wilson HIV medicine 13 (8), 453-468, 2012 | 562 | 2012 |
| Relation between HIV viral load and infectiousness: a model-based analysis DP Wilson, MG Law, AE Grulich, DA Cooper, JM Kaldor The Lancet 372 (9635), 314-320, 2008 | 504 | 2008 |
| Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART F Jin, J Jansson, M Law, GP Prestage, I Zablotska, JCG Imrie, SC Kippax, ... Aids 24 (6), 907-913, 2010 | 415 | 2010 |
| Elasticity of the red cell membrane and its relation to hemolytic disorders: an optical tweezers study J Sleep, D Wilson, R Simmons, W Gratzer Biophysical journal 77 (6), 3085-3095, 1999 | 361 | 1999 |
| HIV prevalence in China: integration of surveillance data and a systematic review L Zhang, EPF Chow, J Jing, X Zhuang, X Li, M He, H Sun, X Li, ... The Lancet infectious diseases 13 (11), 955-963, 2013 | 312 | 2013 |
| “Know your epidemic, know your response”: a useful approach, if we get it right D Wilson, DT Halperin The Lancet 372 (9637), 423-426, 2008 | 308 | 2008 |
| Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies:“STROBE-RDS” statement RG White, AJ Hakim, MJ Salganik, MW Spiller, LG Johnston, L Kerr, ... Journal of clinical epidemiology 68 (12), 1463-1471, 2015 | 275 | 2015 |
| The cost-effectiveness of harm reduction DP Wilson, B Donald, AJ Shattock, D Wilson, N Fraser-Hurt International Journal of Drug Policy 26, S5-S11, 2015 | 244 | 2015 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 238 | 2014 |
| Type III secretion a la Chlamydia J Peters, DP Wilson, G Myers, P Timms, PM Bavoil Trends in microbiology 15 (6), 241-251, 2007 | 238 | 2007 |
| Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand N Ford, D Wilson, GC Chaves, M Lotrowska, K Kijtiwatchakul Aids 21, S21-S29, 2007 | 230 | 2007 |
| Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action FA Akala, I Semini World Bank Publications, 2010 | 212 | 2010 |
| Using complexity and network concepts to inform healthcare knowledge translation A Kitson, A Brook, G Harvey, Z Jordan, R Marshall, R O’Shea, D Wilson International journal of health policy and management 7 (3), 231, 2017 | 196 | 2017 |
| Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men DP Wilson, A Hoare, DG Regan, MG Law Sexual health 6 (1), 19-33, 2009 | 194 | 2009 |
Cliff KerrBill & Melinda Gates FoundationVerified email at gatesfoundation.org
